恒瑞医药截至12月末累计回购A股股份889.87万股

Core Viewpoint - Heng Rui Medicine (600276) announced a share buyback plan, indicating a strategic move to enhance shareholder value through repurchasing shares [1] Group 1: Share Buyback Details - As of December 31, 2025, the company has repurchased a total of 8.8987 million shares through the Shanghai Stock Exchange, representing 0.13% of the total share capital [1] - The highest purchase price for the shares was RMB 70.00 per share, while the lowest was RMB 59.32 per share [1] - The total amount paid for the repurchased shares was RMB 595.2163 million, excluding transaction fees [1]